optic neuritis glp 1 Smaller NAION Risk with Semaglutide Found in Large Population The protective role of GLP-1

The results showed that adults taking the daily 25 mg tablet achieved an average weight loss of ~17% (if staying on treatment)

It is caused by the caloric restriction and rapid weight loss, which trigger a shift of hair follicles from the growth phase to the resting and shedding phase

This can stall your progress and lead to weight regain, potentially making the overall journey longer and less successful

1-6 In some people, complications are more likely to occur at higher doses, even under medical supervision

The interaction between food and GLP-1 medications varies significantly depending on the route of administration and specific product, and understanding these differences is important for achieving optimal therapeutic outcomes